Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120

被引:172
作者
Choe, H
Li, WH
Wright, PL
Vasilieva, N
Venturi, M
Huang, CC
Grundner, C
Dorfman, T
Zwick, MB
Wang, LP
Rosenberg, ES
Kwong, PD
Burton, DR
Robinson, JE
Sodroski, JG
Farzan, M [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med Microbiol & Mol Genet,Div AIDS, Boston, MA 02115 USA
[2] Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA
[3] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA
[4] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol,Div AIDS, Boston, MA 02115 USA
[5] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[6] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[7] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA
[8] Tulane Univ, Med Ctr, Dept Pediat, New Orleans, LA 70012 USA
[9] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
关键词
D O I
10.1016/S0092-8674(03)00508-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sulfated tyrosines at the amino terminus of the principal HIV-1 coreceptor CCR5 play a critical role in its ability to bind the HIV-1 envelope glycoprotein gp120 and mediate HIV-1 infection. Here, we show that a number of human antibodies directed against gp120 are tyrosine sulfated at their antigen binding sites. Like that of CCR5, antibody association with gp120 is dependent on sulfate moieties, enhanced by CD4, and inhibited by sulfated CCR5-derived peptides. Most of these antibodies preferentially associate with gp120 molecules of CCR5-utilizing (R5) isolates and neutralize primary R5 isolates more efficiently than laboratory-adapted isolates. These studies identify a distinct subset of CD4-induced HIV-1 neutralizing antibodies that closely emulate CCR5 and demonstrate that tyrosine sulfation can contribute to the potency and diversity of the human humoral response.
引用
收藏
页码:161 / 170
页数:10
相关论文
共 55 条
[41]   RECOGNITION PROPERTIES OF A PANEL OF HUMAN RECOMBINANT FAB FRAGMENTS TO THE CD4 BINDING-SITE OF GP120 THAT SHOW DIFFERING ABILITIES TO NEUTRALIZE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
ROBEN, P ;
MOORE, JP ;
THALI, M ;
SODROSKI, J ;
BARBAS, CF ;
BURTON, DR .
JOURNAL OF VIROLOGY, 1994, 68 (08) :4821-4828
[42]  
ROSENQUIST GL, 1993, PROTEIN SCI, V2, P215
[43]   Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates [J].
Ross, TM ;
Bieniasz, PD ;
Cullen, BR .
JOURNAL OF VIROLOGY, 1998, 72 (03) :1918-1924
[44]   Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity [J].
Rucker, J ;
Samson, M ;
Doranz, BJ ;
Libert, F ;
Berson, JF ;
Yi, YJ ;
Smyth, RJ ;
Collman, RG ;
Broder, CC ;
Vassart, G ;
Doms, RW ;
Parmentier, M .
CELL, 1996, 87 (03) :437-446
[45]   A DNA vector-based RNAi technology to suppress gene expression in mammalian cells [J].
Sui, GC ;
Soohoo, C ;
Affar, E ;
Gay, F ;
Shi, YJ ;
Forrester, WC ;
Shi, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5515-5520
[46]   CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: Consequences for virus entry and neutralization [J].
Sullivan, N ;
Sun, Y ;
Sattentau, Q ;
Thali, M ;
Wu, D ;
Denisova, G ;
Gershoni, J ;
Robinson, J ;
Moore, J ;
Sodroski, J .
JOURNAL OF VIROLOGY, 1998, 72 (06) :4694-4703
[47]   CHARACTERIZATION OF CONSERVED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 NEUTRALIZATION EPITOPES EXPOSED UPON GP120-CD4 BINDING [J].
THALI, M ;
MOORE, JP ;
FURMAN, C ;
CHARLES, M ;
HO, DD ;
ROBINSON, J ;
SODROSKI, J .
JOURNAL OF VIROLOGY, 1993, 67 (07) :3978-3988
[48]   CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 [J].
Trkola, A ;
Dragic, T ;
Arthos, J ;
Binley, JM ;
Olson, WC ;
Allaway, GP ;
ChengMayer, C ;
Robinson, J ;
Maddon, PJ ;
Moore, JP .
NATURE, 1996, 384 (6605) :184-187
[49]   Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 [J].
Trkola, A ;
Purtscher, M ;
Muster, T ;
Ballaun, C ;
Buchacher, A ;
Sullivan, N ;
Srinivasan, K ;
Sodroski, J ;
Moore, JP ;
Katinger, H .
JOURNAL OF VIROLOGY, 1996, 70 (02) :1100-1108
[50]   PREPARATION AND CHARACTERIZATION OF HUMAN HIV TYPE-1 NEUTRALIZING REFERENCE SERA [J].
VUJCIC, LK ;
QUINNAN, GV .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (07) :783-787